Bone resorption by osteoclasts (OCs) exceeding formation by osteoblasts (OBs) is a biological problem with a central role in widespread and costly disorders, including osteoporosis, osteo- and rheumatoid arthritis, periodontal disease, and prosthesis/implant loosening. Delineation of mechanisms and regulation of the fusion of mononuclear precursors into multinucleated OCs is important since fusion is needed for normal bone resorption. In our studies of gene expression changes during OC differentiation, we discovered OC-STAMP (osteoclast-stimulatory transmembrane protein) and noted a series of striking similarities to a factor shown by others to be essential to fusion, called DC-STAMP. Similarities include 1) up- regulation of mRNA and protein upon stimulation of OC precursors by RANKL;2) predicted topology of transmembrane (TM) helices;3) presence of a DC-STAMP family consensus sequence in the C-terminal half of OC-STAMP;4) suppression of formation of multinucleated osteoclasts in vivo and in vitro by either knockout, knockdown, or antibody;5) stimulation of fusion upon overexpression. Both proteins are highly conserved in terrestrial vertebrates. In a model of acute, induced OC differentiation in an osteopetrotic rat model, we present preliminary evidence that anti-OC-STAMP antibody suppresses osteoclastogenesis in vivo. [A recent report validated our hypothesis that OC-STAMP -/- mice would, like DC-STAMP -/- mice, have mononuclear OCs.] This proposal will investigate pre-OC fusion under 3 Specific Aims to clarify its role in OC cell biology and activity in vivo, as a potential therapeutic targetto control bone loss, and in relation to DC- STAMP as a fusion factor. SA1 will establish the membrane topology of both OC- and DC-STAMP (DC- STAMP has been reported to be a 7-TM superfamily member, yet different algorithms predict different topologies). Information gained should facilitate """"""""next-generation"""""""" antibodies and/or inhibitory peptides directed at proven extracellular loops of these fusigens and provide a basis for further hypotheses about activities and regulation. Under SA2, OC- and DC-STAMP knockout mice will be produced (requests for existing lines were refused). We will confirm the skeletal and OC phenotypes of both strains in our hands, and we will use cells derived from them to perform fusion experiments to determine interaction or interdependence of OC- and DC- STAMP for fusion. Studies will be done to identify potential ligands and regulatory factors for OC- and DC- STAMP. Under SA3, we will increase the size of our preliminary study of acute, in vivo OC inhibition in tl/tl rats with anti-C-STAMP antibody. We will also investigate the effects of anti-[fusigens] antibody inhibition in the proven, ovariectomized rat model of osteoporosis using athymic rats. Together, these studies should provide significant new information about the topology and cell biology of both OC-STAMP and DC-STAMP, about pre- OC fusion, about the phenotypic impact of loss of OC-STAMP on the skeleton, and whether in principle, inhibition of pre-OC fusion is a valid approach to stemming bone loss in vivo.

Public Health Relevance

Widespread bone disorders, including osteoporosis, arthritis, periodontal bone disease, joint replacement loosening, and tumor metastasis to bone, all have in common bone loss that exceeds bone formation. Bone loss is carried out by specialized cells called osteoclasts, and the more deeply we understand how osteoclasts work, the more opportunities will arise for potential therapeutics to control their activity. This proposal aims t investigate a new gene we discovered called OC-STAMP which regulates cell-cell fusion by pre-osteoclasts in forming a mature and active cell. Deeper understanding of this gene and how it controls the bone resorbing activity of osteoclasts will give a better knowledge of bone biology in general, and potentially will lead to new ways to treat these all-too-common, crippling, and costly bone disorders.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Project (R01)
Project #
Application #
Study Section
Skeletal Biology Development and Disease Study Section (SBDD)
Program Officer
Chen, Faye H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Massachusetts Medical School Worcester
Anatomy/Cell Biology
Schools of Medicine
United States
Zip Code
Odgren, Paul R; Witwicka, Hanna; Reyes-Gutierrez, Pablo (2016) The cast of clasts: catabolism and vascular invasion during bone growth, repair, and disease by osteoclasts, chondroclasts, and septoclasts. Connect Tissue Res 57:161-74
Witwicka, Hanna; Jia, Hong; Kutikov, Artem et al. (2015) TRAFD1 (FLN29) Interacts with Plekhm1 and Regulates Osteoclast Acidification and Resorption. PLoS One 10:e0127537
Ye, Liang; Morse, Leslie R; Zhang, Li et al. (2015) Osteopetrorickets due to Snx10 deficiency in mice results from both failed osteoclast activity and loss of gastric acid-dependent calcium absorption. PLoS Genet 11:e1005057
Witwicka, Hanna; Hwang, Sung-Yong; Reyes-Gutierrez, Pablo et al. (2015) Studies of OC-STAMP in Osteoclast Fusion: A New Knockout Mouse Model, Rescue of Cell Fusion, and Transmembrane Topology. PLoS One 10:e0128275